Meningeal immunity and neurological diseases: new approaches, new insights

J Neuroinflammation. 2023 May 25;20(1):125. doi: 10.1186/s12974-023-02803-z.

Abstract

The meninges, membranes surrounding the central nervous system (CNS) boundary, harbor a diverse array of immunocompetent immune cells, and therefore, serve as an immunologically active site. Meningeal immunity has emerged as a key factor in modulating proper brain function and social behavior, performing constant immune surveillance of the CNS, and participating in several neurological diseases. However, it remains to be determined how meningeal immunity contributes to CNS physiology and pathophysiology. With the advances in single-cell omics, new approaches, such as single-cell technologies, unveiled the details of cellular and molecular mechanisms underlying meningeal immunity in CNS homeostasis and dysfunction. These new findings contradict some previous dogmas and shed new light on new possible therapeutic targets. In this review, we focus on the complicated multi-components, powerful meningeal immunosurveillance capability, and its crucial involvement in physiological and neuropathological conditions, as recently revealed by single-cell technologies.

Keywords: Meningeal immunity; Meninges; Neurodegenerative disease; Neuroinflammatory disease; Single-cell technologies.

Publication types

  • Review

MeSH terms

  • Central Nervous System
  • Humans
  • Meninges*
  • Nervous System Diseases*